期刊文献+

维持性血液透析患者同型半胱氨酸与左心室结构和功能的关系 被引量:2

Relationship between homocysteic acid and left ventricular structure and function of maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨维持性血液透析(MHD)患者同型半胱氨酸与左心室结构和功能的关系。方法选择我院MHD患者58例(血透组)、体检中心30例健康体检者(对照组),检测两组受试者血浆总同型半胱氨酸(tHcy)浓度,用彩色多普勒超声测定左心室舒张末期内径(LVDd)与容积(LVVd)、左心室收缩末期内径(LVDs)与容积(LVVs)、左心室后壁厚度(LVP-WT)、室间隔厚度(IVST)、左心室射血分数(LVEF)、左心室质量指数(LVMI)及舒张早期、晚期最大血流比(E/A),分析tHcy与上述各参数间的关系。结果血透组患者血浆tHcy浓度、LVDd、LVDs、IVST、LVPWT、E/A、射血分数(EF)和LVMI均明显高于对照组,差异有统计学意义(P<0.01);tHcy水平与LVD、IVST、LVMI呈显著正相关,与EF、E/A呈显著负相关。结论 MHD患者存在高同型半胱氨酸血症,tHcy浓度可作为心脏左心室肥厚和功能减退的预测因子。 Objective To evaluate the relationship between homocysteic acid(HCA) and left ventricular structure and function of maintenance hemodialysis(MHD)patients.Methods We selected 58 cases of MHD patients as test group and 30 cases of health controls.Plasma total homocysteine(tHcy)was tested.Left ventricular end diastolic dimension(LVDd),left ventricular end-diastole volume(LVVd),left ventricular end-systolic dimension(LVDs),left ventricular end-systolic volume(LVVs),left ventricular posterior wall thickness(LVPWT),interventricular septal thickness(IVST),left ventricular ejection fraction(LVEF),left ventricular mass index(LVMI),and ratio of early diastolic flowvelocity and late diastolic flow velocity(E/A)were tested by color Doppler ultrasound.The relationship between tHcy and the above-mentioned parameters was analyzed.Results The tHcy concentration,LVDd,LVDs,IVST,LVPWT,E/A,EF and LVMI in test group were significantly higher than those in control group(P0.01).The tHcy level was positively correlated to LVD,IVST and LVMI,and negatively correlated to EF and E/A.Conlusion For MHD patients with high HCA,tHcy concentration can be used as a predictor for left ventricular hypertrophy and left ventricular dysfunction.
出处 《实用医院临床杂志》 2011年第3期30-32,共3页 Practical Journal of Clinical Medicine
关键词 维持性血液透析 同型半胱氨酸 左心室结构 左心室功能 Maintenance hemodialysis Homocysteic acid Left ventricular structure Left ventricular function
  • 相关文献

参考文献11

  • 1Centers for disease control and prevention (CDC).Statespecific trends in chronic kidney failure,United States,1990-2001[J].MMWR Morb Mortal Wkly Rep,2004,53:918-920.
  • 2杨松涛,覃莲香,胡军,肖跃飞.血液透析患者血浆同型半胱氨酸与心血管疾病的关系[J].中国血液净化,2009,8(12):665-668. 被引量:8
  • 3Herrmann W,Herrmann M,Obeid R.Hyperhomocysteinemia:a critical review of old and new aspects[J].Curr Drug Metab,2007,8:17-31.
  • 4周进,刘牧.不同血红蛋白水平对维持性血液透析患者心血管事件发生率的影响[J].四川医学,2009,30(12):1917-1918. 被引量:1
  • 5Deverux RB,Reichek N.Echocardiographic determination of left ventricularmass in man:anatomic validation of the method[J].Circulation,1977,7 (1):571-581.
  • 6Reichek N,Deverux RB.Left ventricular hypertrophy:Relatioship of anatomic,echocardiographic and electrocardiographic findings[J].Circulation,1981,63 (4):1391-1398.
  • 7Buccianti G,Baragetti I,Bamonti F,et al.Plasma homocysteine levels and cardiovascular mortality in patientswith end-stage renal disease[J].J Nephrol,2004,17:405-410.
  • 8田军,张金元,胡大勇.肾功能损害对血浆同型半胱氨酸浓度的影响[J].中国血液净化,2005,4(10):542-544. 被引量:9
  • 9Guttormsen AB,Ueland PM,Faglia G,et al.Kinetic basis of hyperhomocysteinemia in patient chronic renal failure[J].Kidney International,1997,52:495-502.
  • 10Suliman ME,Stenvinkel P,Heimbürger O,et al.Plasma sulfur amino acids in relation to cardiovascular disease,nutritional status,and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy[J].Am J Kidney Dis,2002,40:480-488.

二级参考文献29

  • 1田军,张金元,胡大勇.肾功能损害对血浆同型半胱氨酸浓度的影响[J].中国血液净化,2005,4(10):542-544. 被引量:9
  • 2Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 3Centers for disease control and prevention (CDC).Statespecific trends in chronic kidney failure, United States, 1990-2001[J].MMWR Morb Mortal Wkly ReD, 2004, 53: 918-920.
  • 4Locatelli F, Marcelli D, Conte F. Cardiovascular disease in chronic renal failure: The challenge continues[J]. Nephrol Dial Transplant, 2000, 15:69-80.
  • 5Oishi K, Nagake Y, Yamasaki H, et al. The significance of atherogenic indices in patients on hemodialysis [J]. Am J Nephrol, 2000,20:107-115.
  • 6Herrmann W, Herrmann M, Obeid R. Hyperhomocysteinemia: a critical review of old and new aspects[J]. Curt Drug Metab, 2007, 8:17-31.
  • 7Buccianti G, Baragetti I, Bamonti F, et al. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease[J]. J Nephrol, 2004, 17:405-410.
  • 8Guttormsen AB, Ueland PM, Faglia G, et al. Kinetic basis of hyperhomocysteinemia in patient chronic renal failure [J]. Kidney International, 1997, 52:495-502.
  • 9Suliman ME, Stenvinkel P, Heimbu rger O, et al. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy [J]. Am .J Kidney Dis. 2002, 40:480-488.
  • 10Shukla N, Thompson CS, Angelini GD, et al. Homocysteine enhances impairment of endothelium-dependent relaxation and gnanosine cyclic monophosphate formation in aortae from diabetic rabbits[J]. Diabetologia, 2002, 45:1325- 1331.

共引文献47

同被引文献11

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部